NASDAQ · Financial Statements
Singular Genomics Systems, Inc. (OMIC) Financial Statements
$20.01
NASDAQ: OMIC
Market Cap $50.77M
Overview Financials Dividend
Singular Genomics Systems, Inc. most recently reported annual revenue of $3.0M, a net loss of $95.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023
Revenue $0 $0 $0 $1.0M $3.0M Operating Profit $-13.0M $-28.0M $-61.0M $-93.0M $-103.0M Net Profit $-12.0M $-29.0M $-99.0M $-88.0M $-95.0M EPS $-5.34 $-12.41 $-40.95 $-37.22 $-39.08 Op Margin — — — -12220.5% -3531.5%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023
Total Assets $48.0M $31.0M $356.0M $328.0M $265.0M Total Liabilities $73.0M $82.0M $19.0M $68.0M $86.0M Cash $6.0M $12.0M $201.0M $74.0M $16.0M Borrowings $2.0M $9.0M $10.0M $59.0M $75.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023
Operating Cash Flow $-11.0M $-25.0M $-52.0M $-87.0M $-74.0M Investing Cash Flow $-32.0M $23.0M $-136.0M $-46.0M $13.0M Financing Cash Flow $0 $0 $4.0M $1.0M $1.0M Net Cash Flow $4.0M $7.0M $190.0M $-126.0M $-59.0M Free Cash Flow $-12.0M $-26.0M $-57.0M $-93.0M $-75.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.09 EV / EBITDA -1.27 FCF Yield -146.98% Quick Ratio 9.77 Interest Coverage -93.37 Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .